211 related articles for article (PubMed ID: 24699309)
1. Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling.
Bénit P; Letouzé E; Rak M; Aubry L; Burnichon N; Favier J; Gimenez-Roqueplo AP; Rustin P
Biochim Biophys Acta; 2014 Aug; 1837(8):1330-7. PubMed ID: 24699309
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL
Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546
[TBL] [Abstract][Full Text] [Related]
3. Krebs cycle dysfunction shapes epigenetic landscape of chromatin: novel insights into mitochondrial regulation of aging process.
Salminen A; Kaarniranta K; Hiltunen M; Kauppinen A
Cell Signal; 2014 Jul; 26(7):1598-603. PubMed ID: 24704120
[TBL] [Abstract][Full Text] [Related]
4. Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites.
Serra-Pérez A; Planas AM; Núñez-O'Mara A; Berra E; García-Villoria J; Ribes A; Santalucía T
J Biol Chem; 2010 Jun; 285(24):18217-24. PubMed ID: 20368331
[TBL] [Abstract][Full Text] [Related]
5. Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process.
Salminen A; Kauppinen A; Hiltunen M; Kaarniranta K
Ageing Res Rev; 2014 Jul; 16():45-65. PubMed ID: 24910305
[TBL] [Abstract][Full Text] [Related]
6. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
[TBL] [Abstract][Full Text] [Related]
7. The dual-functioning fumarate reductase is the sole succinate:quinone reductase in Campylobacter jejuni and is required for full host colonization.
Weingarten RA; Taveirne ME; Olson JW
J Bacteriol; 2009 Aug; 191(16):5293-300. PubMed ID: 19525346
[TBL] [Abstract][Full Text] [Related]
8. The Role of Succinate in Regulation of Immediate HIF-1α Expression in Hypoxia.
Lukyanova LD; Kirova YI; Germanova EL
Bull Exp Biol Med; 2018 Jan; 164(3):298-303. PubMed ID: 29308570
[TBL] [Abstract][Full Text] [Related]
9. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
10. A spectrophotometric coupled enzyme assay to measure the activity of succinate dehydrogenase.
Jones AJ; Hirst J
Anal Biochem; 2013 Nov; 442(1):19-23. PubMed ID: 23886887
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions.
Brière JJ; Favier J; Bénit P; El Ghouzzi V; Lorenzato A; Rabier D; Di Renzo MF; Gimenez-Roqueplo AP; Rustin P
Hum Mol Genet; 2005 Nov; 14(21):3263-9. PubMed ID: 16195397
[TBL] [Abstract][Full Text] [Related]
12. Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
Her YF; Nelson-Holte M; Maher LJ
PLoS One; 2015; 10(5):e0127471. PubMed ID: 25985299
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
14. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization.
Porcelli AM; Ghelli A; Ceccarelli C; Lang M; Cenacchi G; Capristo M; Pennisi LF; Morra I; Ciccarelli E; Melcarne A; Bartoletti-Stella A; Salfi N; Tallini G; Martinuzzi A; Carelli V; Attimonelli M; Rugolo M; Romeo G; Gasparre G
Hum Mol Genet; 2010 Mar; 19(6):1019-32. PubMed ID: 20028790
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors.
Kitazawa S; Ebara S; Ando A; Baba Y; Satomi Y; Soga T; Hara T
Oncotarget; 2017 Apr; 8(17):28922-28938. PubMed ID: 28423651
[TBL] [Abstract][Full Text] [Related]
16. Succinate: a metabolic signal in inflammation.
Mills E; O'Neill LA
Trends Cell Biol; 2014 May; 24(5):313-20. PubMed ID: 24361092
[TBL] [Abstract][Full Text] [Related]
17. Succinate in ischemia: Where does it come from?
Chinopoulos C
Int J Biochem Cell Biol; 2019 Oct; 115():105580. PubMed ID: 31394174
[TBL] [Abstract][Full Text] [Related]
18. Inborn errors of complex II--unusual human mitochondrial diseases.
Rustin P; Rötig A
Biochim Biophys Acta; 2002 Jan; 1553(1-2):117-22. PubMed ID: 11803021
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
Hollinshead KE; Tennant DA
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
